(Q37287179)

19 August 2017

1 reference

title

NKG2D ligands in tumor immunity (English)

1 reference

19 August 2017

N Nausch

1

1 reference

19 August 2017

A Cerwenka

series ordinal

2

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 October 2008

1 reference

19 August 2017

1 reference

19 August 2017

volume

27

1 reference

19 August 2017

issue

45

1 reference

19 August 2017

page(s)

5944-5958

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2008.272

19 August 2017

exact match

0 references

cites work

Function and regulation of AP-1 subunits in skin physiology and pathology

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Two human ULBP/RAET1 molecules with transmembrane regions are ligands for NKG2D

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

A second lineage of mammalian major histocompatibility complex class I genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Regulatory T cells in ovarian cancer: biology and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

BCR/ABL oncogene directly controls MHC class I chain-related molecule A expression in chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

The NKG2D-activating receptor mediates pulmonary clearance of Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Polymorphism of the transmembrane region of the MICA gene and human brucellosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

IFN-dependent down-regulation of the NKG2D ligand H60 on tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

IL-21 down-regulates NKG2D/DAP10 expression on human NK and CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

RAET1E2, a soluble isoform of the UL16-binding protein RAET1E produced by tumor cells, inhibits NKG2D-mediated NK cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

DNAX Accessory Molecule-1 Mediated Recognition of Freshly Isolated Ovarian Carcinoma by Resting Natural Killer Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Both CD133+ and CD133- medulloblastoma cell lines express ligands for triggering NK receptors and are susceptible to NK-mediated cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Ligands for natural killer cell receptors: redundancy or specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

ULBP4 is a novel ligand for human NKG2D

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Inhibition of NK cell activity through TGF-beta 1 by down-regulation of NKG2D in a murine model of head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

NKG2D ligand expression in AML increases in response to HDAC inhibitor valproic acid and contributes to allorecognition by NK-cell lines with single KIR-HLA class I specificities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Promiscuity and the single receptor: NKG2D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Engagement of NKG2D by cognate ligand or antibody alone is insufficient to mediate costimulation of human and mouse CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

The activating NKG2D receptor assembles in the membrane with two signaling dimers into a hexameric structure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Regulation of cutaneous malignancy by gammadelta T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

The genomic organization of NKG2C, E, F, and D receptor genes in the human natural killer gene complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Fas-ligand-mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

TNFalpha stimulates NKG2D-mediated lytic activity of acute myeloid leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

In vivo selection for metastasis promoting genes in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Cutting edge: Toll-like receptor signaling in macrophages induces ligands for the NKG2D receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

NK cells in innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Murine Nkg2d and Cd94 are clustered within the natural killer complex and are expressed independently in natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Soluble MICB in malignant diseases: analysis of diagnostic significance and correlation with soluble MICA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Soluble MICA in malignant diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

The treatment of melanoma with an emphasis on immunotherapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

The role of the NKG2D immunoreceptor in immune cell activation and natural killing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Critical role of MHC class I-related chain A and B expression on IFN-alpha-stimulated dendritic cells in NK cell activation: impairment in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

NKG2D-independent suppression of T cell proliferation by H60 and MICA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Dendritic cells prime natural killer cells by trans-presenting interleukin 15

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

NKG2D engagement of colorectal cancer-specific T cells strengthens TCR-mediated antigen stimulation and elicits TCR independent anti-tumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Regulation of ligands for the activating receptor NKG2D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

NF-kappa B regulates expression of the MHC class I-related chain A gene in activated T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Cancer regression in patients after transfer of genetically engineered lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Cutting edge: the AP-1 subunit JunB determines NK cell-mediated target cell killing by regulation of the NKG2D-ligand RAE-1epsilon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Reciprocal regulation of human natural killer cells and macrophages associated with distinct immune synapses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Genomic structures and characterization of Rae1 family members encoding GPI-anchored cell surface proteins and expressed predominantly in embryonic mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Ligands for natural killer cell-activating receptors are expressed upon the maturation of normal myelomonocytic cells but at low levels in acute myeloid leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Molecular Competition for NKG2D

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Function of NKG2D in natural killer cell-mediated rejection of mouse bone marrow grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

NKG2D in NK and T cell-mediated immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

The switch from latent to productive infection in epstein-barr virus-infected B cells is associated with sensitization to NK cell killing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Vdelta1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

NKG2D splice variants: a reexamination of adaptor molecule associations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Activated, but not resting, T cells can be recognized and killed by syngeneic NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

A cluster of ten novel MHC class I related genes on human chromosome 6q24.2-q25.3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Intercellular protein transfer at the NK cell immune synapse: mechanisms and physiological significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Transfer of NKG2D and MICB at the cytotoxic NK cell immune synapse correlates with a reduction in NK cell cytotoxic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

DNA damage-induced cell death by apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

A Structural basis for the association of DAP12 with mouse, but not human, NKG2D

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependent NK cell lysis and tumor rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Release of MICB molecules by tumor cells: mechanism and soluble MICB in sera of cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Cutting Edge: Down-Regulation of MICA on Human Tumors by Proteolytic Shedding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

In vivo expression pattern of MICA and MICB and its relevance to auto-immunity and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Cytokine and contact-dependent activation of natural killer cells by influenza A or Sendai virus-infected macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

NKG2D function protects the host from tumor initiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

IL-2/IL-18 prevent the down-modulation of NKG2D by TGF-beta in NK cells via the c-Jun N-terminal kinase (JNK) pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Asymmetric ligand recognition by the activating natural killer cell receptor NKG2D, a symmetric homodimer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

A novel dendritic cell subset involved in tumor immunosurveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Two novel NKG2D ligands of the mouse H60 family with differential expression patterns and binding affinities to NKG2D

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

IL-21 enhances tumor rejection through a NKG2D-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

New agents for the treatment of acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

T cells gene-engineered with DAP12 mediate effector function in an NKG2D-dependent and major histocompatibility complex-independent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Binding of Escherichia coli adhesin AfaE to CD55 triggers cell-surface expression of the MHC class I-related molecule MICA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

The contribution of genotypes at the MICA gene triplet repeat polymorphisms and MEFV mutations to amyloidosis and course of the disease in the patients with familial Mediterranean fever.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Promoter region architecture and transcriptional regulation of the genes for the MHC class I-related chain A and B ligands of NKG2D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Blockade of NKG2D on NKT cells prevents hepatitis and the acute immune response to hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

CD11cloB220+ interferon-producing killer dendritic cells are activated natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Proteolytic release of soluble UL16-binding protein 2 from tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

HIV modulates the expression of ligands important in triggering natural killer cell cytotoxic responses on infected primary T-cell blasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Expression of the stress-related MHC class I chain-related protein MICA is an indicator of good prognosis in colorectal cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Contribution of the Atm protein to maintaining cellular homeostasis evidenced by continuous activation of the AP-1 pathway in Atm-deficient brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

An activating immunoreceptor complex formed by NKG2D and DAP10

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Opposing effect of IFNgamma and IFNalpha on expression of NKG2 receptors: negative regulation of IFNgamma on NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Chimeric NKG2D modified T cells inhibit systemic T-cell lymphoma growth in a manner involving multiple cytokines and cytotoxic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Chimeric NK-receptor-bearing T cells mediate antitumor immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

A DNA-based cancer vaccine enhances lymphocyte cross talk by engaging the NKG2D receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

DNA-based vaccines activate innate and adaptive antitumor immunity by engaging the NKG2D receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Isolation and characterization of retinoic acid-inducible cDNA clones in F9 cells: a novel cDNA family encodes cell surface proteins sharing partial homology with MHC class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

CD4+NKG2D+ T Cells in Crohn’s Disease Mediate Inflammatory and Cytotoxic Responses Through MICA Interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

MIC and other NKG2D ligands: from none to too many.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Expansion of Vdelta1 T lymphocytes producing IL-4 in low-grade non-Hodgkin lymphomas expressing UL-16-binding proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK- cell lysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Mechanisms involved in synergistic anticancer immunity of anti-4-1BB and anti-CD4 therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

NKG2D signaling is coupled to the interleukin 15 receptor signaling pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Survival versus neglect: redefining thymocyte subsets based on expression of NKG2D ligand(s) and MHC class I

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Soluble MIC is elevated in the serum of patients with pancreatic carcinoma diminishing gammadelta T cell cytotoxicity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Liver dendritic cells are less immunogenic than spleen dendritic cells because of differences in subtype composition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Interleukin-15 mediates protection against experimental tuberculosis: a role for NKG2D-dependent effector mechanisms of CD8+ T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

Expression of stress-induced MHC class I related chain molecules on human melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.272

31 March 2020

Identifiers

DOI

10.1038/ONC.2008.272

1 reference

19 August 2017

1 reference